Stock Detail
RTI BIOLOGICS INC
Biotechnology
RTIX @ Yahoo Finance | RTIX Option @ Yahoo Finance
Last Day's Data
| Current Price | High | Value Change | Percent Change | Dividend | Previous Close |
|---|---|---|---|---|---|
| $4.40 | $4.50 | $0.08 | 1.85% | 0.00 | $4.32 |
| Opening Price | Low | Volume | Market Cap | Average Volume | P/E |
| $4.31 | $4.25 | 675,984 | 242.58M | 484,378 | 26.53 |
Pivot Table
| R2 | R1 | Pivot | S1 | S2 |
| 4.63 | 4.51 | 4.38 | 4.26 | 4.13 |
Stock Profile
Regeneration Technologies, Inc. and its subsidiaries engage in the processing and sterilization of human tissue into allograft implants for orthopedic, oral maxillofacial, urinary, and cardiovascular surgeries. It processes human musculoskeletal and other tissues, including bone, cartilage, tendon, ligament, pericardial, and cardiovascular tissue in producing allograft implants. These tissues are used by surgeons to repair and promote the healing of various bone and other tissue defects, including spinal vertebrae repair, musculoskeletal reconstruction, fracture repair, repairs to the jaw and related tissues, and heart valve disorders. The company's processed Allografts include its patented MD Series Threaded Cortical Bone Dowels, Cornerstone Machined Allografts, Tangent Impacted Cortical Wedges, Opteform and Optefil allograft pastes, Osteofil/Regenafil injectable bone paste, and Precision Graft Cortical Rings. Regeneration Technologies provides its portfolio of products in a range of markets, including spinal, sports medicine, cardiovascular, and other general orthopedic applications. It distributes its products in the United States, Korea, and Europe. The company was incorporated in 1997 and is headquartered in Alachua, Florida.